SmartSteward Revenue and Competitors
Estimated Revenue & Valuation
- SmartSteward's estimated annual revenue is currently $362.5k per year.
- SmartSteward's estimated revenue per employee is $72,500
Employee Data
- SmartSteward has 5 Employees.
- SmartSteward grew their employee count by 0% last year.
SmartSteward's People
Name | Title | Email/Phone |
---|
SmartSteward Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.7M | 67 | 14% | N/A | N/A |
#2 | $27.3M | 175 | -3% | $10M | N/A |
#3 | $265.1M | 1306 | -16% | N/A | N/A |
#4 | $8.9M | 68 | -8% | N/A | N/A |
#5 | $28.4M | 178 | -12% | N/A | N/A |
#6 | $5M | 45 | 13% | $16.8M | N/A |
#7 | $36.2M | 227 | -8% | N/A | N/A |
#8 | $19.7M | 136 | 5% | N/A | N/A |
#9 | $12.9M | 89 | 5% | $7M | N/A |
#10 | $231M | 1138 | 9% | N/A | N/A |
What Is SmartSteward?
SmartSteward™ is the first and only intelligent software specifically designed to detect deadly viruses and multidrug resistant organisms (MDRO) in skilled nursing facilities as well as serve as a decision support platform, delivering data to the doctors and nurses at the moment they need it. SmartSteward™Inc., located at the University of Florida’s UF Innovate | The Hub, has developed a software platform called SmartSteward™ that automates infection control and antibiotic stewardship in skilled nursing facilities. SmartSteward™ software helps facilities reduce infections and readmissions by optimizing the use of antibiotics, automating infection detection and reducing facility antibiotic resistance patterns. Learn more at https://smartsteward.co.
keywords:N/AN/A
Total Funding
5
Number of Employees
$362.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 5 | N/A | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | $0.4M | 5 | 25% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | -17% | N/A |